Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hydroxyproline + leucine is a combination of two amino acids primarily investigated for its potential synergistic effects on collagen synthesis, skin health, and muscle protein metabolism. Hydroxyproline is a major constituent of collagen, while leucine is an essential branched-chain amino acid (BCAA) that acts as a potent activator of the mechanistic target of rapamycin complex 1 (mTORC1) signaling pathway, which regulates protein synthesis. This combination is often found in dietary supplements and medical foods aimed at improving skin elasticity, supporting joint health, or mitigating age-related muscle loss (sarcopenia). Clinical research has explored its efficacy in enhancing muscle mass and skin rejuvenation, suggesting that the two components work together to stimulate tissue repair and anabolic processes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on hydroxyproline + leucine.